at end of follow-up has to be the minimum of (1) the age of death from lung cancer, (2) the age of death from other causes, or (3) the age at other causes of censoring-whereas controls are followed to the minimum of (2) and (3) only.
Further, controls' follow-up time in the simulations tends to begin at an older age than cases'. This is because, to be chosen, controls must be followed at the age of the event in the case, and (as is standard) follow-up time is truncated when the control reaches the age of the index case. In the simulations, therefore, average follow-up time in controls will tend to be less than in cases, which are randomly selected from the cohort and have untruncated follow-up times. Similarly, all measures of exposure that depend on follow-up time (such as duration, average, and cumulative exposure) are distorted even when everyone receives the same level of exposure during follow-up. This phenomenon can be seen in the second row (and possibly the first row) of Table 2 of the paper by Deubner et al 3 where, in the absence of an exposure effect, the cumulative exposure of cases (proportional to follow-up time when exposure is constant) is greater than that of controls. In contrast, average cumulative exposure in cases and controls are similar when the hazard ratio is 1 in simulations that generate a random cohort (Table 1 , rows 1 and 2). 2 So why does proportional hazards analysis truncate exposures for controls but not for cases? In proportional hazards analysis of full cohorts and nested case-control studies, the key calculation is the set of conditional probabilities that each case is the one who developed disease among all those in the cohort (or among the case and matched controls in the nested case-control study) under follow-up at case's age at event, given everyone's exposure through that age. Logically, any exposure in the case after the event cannot be related to risk at the time of event. Similarly, the other cohort members' exposures subsequent to the index case's age at event also should not be allowed to affect the conditional probability of the event.
I do not agree with Deubner et al that lagging raises special concerns. A lagged measure of exposure with lag L bases risk at a given time point t only on exposure through time point t Ϫ L. Lagging is simply one way to measure exposure, and does not differ fundamentally from choosing other metrics such as average exposure, peak exposure, or cumulative exposure without lagging. 1 As long as exposure is measured only up to the time of the event, the particular choice of exposure summary cannot introduce bias in comparing cases and controls. 1 In their second paper, Deubner et al (this time with Levy as the first author 4 ) suggest the use of risk-set members' age at the end of follow-up as a control selection criterion. Specifically, they advocate choosing only controls whose age at end of follow-up is close to the index case's age at death in order to avoid imbalance between cases and controls in age at start of follow-up or of first exposure and in age at censoring. Unfortunately, the use of risk set members' age at end of follow-up as a control selection criterion generates nonrandom samples. As Lubin row 3) show that there is a bias generated from a nonrandom sample with controls who are younger at end of follow-up than the average in the risk set. The extra restriction proposed by Levy et al 4 can also cause another bias: if a time-independent exposure, one whose value is constant during follow-up, causes censoring due to death from another cause, the average exposure of cohort members in the risk set with follow-up even only slightly beyond the time of diagnosis of the case will tend to be less than the average in the risk set. Thus, the difference in exposure between cases and controls-and its estimated effect-will be exaggerated, even under the usual assumption of independent censoring. By contrast, the full cohort analysis will not have an analogous restriction and will be valid under independent censoring.
In my view, the 2 papers published in this issue 1,2 and the arguments offered here provide a persuasive defense of the standard analytic approach for nested case control designs. The arguments by Deubner et al 3, 4 about lagged exposure do not in fact undermine the standard analysis. The setup of their simulation contains an error, and their results are not confirmed by others. These authors offer no explanation of why the bias with lagged exposures would be restricted to nested case-control studies and not be present in the full cohort analysis. Their suggestion of nonrandom selection of controls could itself induce bias. Taking all things into account, their critique is not a valid criticism of this familiar and useful epidemiologic approach. Even so, such challenges to the status quo as offered by Deubner et al are not without benefit-they push us to a better understanding of the fundamental principles that underlie our methods.
